Novartis Investigative Site

Lahti 15850

0 studies enrolling now · 1 studies all time

What they study most

Giant Cell Arteritis (GCA)

Studies at this site

• Phase III Study of Efficacy and Safety of Secukinumab Versus Placebo, in Combination With Glucocorticoid Taper Regimen, in Patients With Giant Cell Arteritis (GCA) — Completed